Plant ID: NPO3846
Plant Latin Name: Melia indica
Taxonomy Genus: Melia
Taxonomy Family: Meliaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
China
FYN; LCK; MAPK1; MAPK14; | |
CA2; CA7; CA4; CA12; | |
SLCO1B1; | |
L3MBTL1; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 5 | TBXAS1 | Thromboxane-A synthase | P24557 | CHEMBL1835 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Methyl-lysine/arginine binding protein | L3MBTL1 | Lethal(3)malignant brain tumor-like protein 1 | Q9Y468 | CHEMBL1287622 |
Protein Kinase | FYN | Tyrosine-protein kinase FYN | P06241 | CHEMBL1841 |
Protein Kinase | LCK | Tyrosine-protein kinase LCK | P06239 | CHEMBL258 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Protein Kinase | MAPK14 | MAP kinase p38 alpha | Q16539 | CHEMBL260 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.161E-10 | 2.528E-06 | CA12, CA2, CA4, CA7 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 4.975E-09 | 5.417E-05 | CA12, CA2, CA4, CA7 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.144E-08 | 8.300E-05 | CA12, CA2, CA4, CA7 |
MF | GO:0005488; binding | GO:0042610; CD8 receptor binding | 3.538E-07 | 1.101E-03 | FYN, LCK |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 1.061E-06 | 2.567E-03 | CA2, CA7 |
MF | GO:0005488; binding | GO:0046914; transition metal ion binding | 9.787E-07 | 2.567E-03 | CA12, CA2, CA4, CA7, CYP1A2, L3MBTL1, TBXAS1 |
BP | Unclassified; | GO:2000021; regulation of ion homeostasis | 6.043E-06 | 8.773E-03 | CA2, CA7, FYN, LCK |
MF | GO:0005488; binding | GO:0042608; T cell receptor binding | 7.417E-06 | 9.500E-03 | FYN, LCK |
MF | GO:0005488; binding | GO:0042609; CD4 receptor binding | 7.417E-06 | 9.500E-03 | FYN, LCK |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.760E-10 | 2.024E-08 | CA12, CA2, CA4, CA7 |
09150 Organismal Systems | 09151 Immune system | hsa04660 | T cell receptor signaling pathway | 3.307E-07 | 1.902E-05 | LCK, MAPK1, FYN, MAPK14 |
09150 Organismal Systems | 09151 Immune system | hsa04611 | Platelet activation | 6.281E-07 | 2.408E-05 | TBXAS1, MAPK1, FYN, MAPK14 |
09150 Organismal Systems | 09158 Development | hsa04380 | Osteoclast differentiation | 8.613E-07 | 2.476E-05 | LCK, MAPK1, FYN, MAPK14 |
09150 Organismal Systems | 09151 Immune system | hsa04664 | Fc epsilon RI signaling pathway | 8.091E-06 | 1.861E-04 | MAPK1, FYN, MAPK14 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04071 | Sphingolipid signaling pathway | 4.455E-05 | 8.539E-04 | MAPK1, FYN, MAPK14 |
09150 Organismal Systems | 09151 Immune system | hsa04650 | Natural killer cell mediated cytotoxicity | 6.329E-05 | 1.040E-03 | LCK, MAPK1, FYN |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04370 | VEGF signaling pathway | 5.922E-04 | 6.046E-03 | MAPK1, MAPK14 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05020 | Prion diseases | 1.942E-04 | 2.482E-03 | MAPK1, FYN |
09150 Organismal Systems | 09151 Immune system | hsa04621 | NOD-like receptor signaling pathway | 5.171E-04 | 5.947E-03 | MAPK1, MAPK14 |
09150 Organismal Systems | 09152 Endocrine system | hsa04917 | Prolactin signaling pathway | 8.241E-04 | 6.046E-03 | MAPK1, MAPK14 |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 8.291E-05 | 1.192E-03 | CA2, CA4 |
09160 Human Diseases | 09167 Infectious diseases | hsa05140 | Leishmaniasis | 8.470E-04 | 6.046E-03 | MAPK1, MAPK14 |
09160 Human Diseases | 09167 Infectious diseases | hsa05131 | Shigellosis | 6.722E-04 | 6.046E-03 | MAPK1, MAPK14 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 8.014E-04 | 6.046E-03 | SLCO1B1, CA2 |
09140 Cellular Processes | 09144 Cellular community - eukaryotes | hsa04520 | Adherens junction | 8.702E-04 | 6.046E-03 | MAPK1, FYN |
09150 Organismal Systems | 09152 Endocrine system | hsa04912 | GnRH signaling pathway | 1.312E-03 | 7.941E-03 | MAPK1, MAPK14 |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.612E-03 | 8.429E-03 | MAPK1, MAPK14 |
09150 Organismal Systems | 09152 Endocrine system | hsa04914 | Progesterone-mediated oocyte maturation | 1.519E-03 | 8.429E-03 | MAPK1, MAPK14 |
09150 Organismal Systems | 09156 Nervous system | hsa04723 | Retrograde endocannabinoid signaling | 1.612E-03 | 8.429E-03 | MAPK1, MAPK14 |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 8.938E-04 | 6.046E-03 | MAPK1, MAPK14 |
09150 Organismal Systems | 09156 Nervous system | hsa04725 | Cholinergic synapse | 1.943E-03 | 8.593E-03 | MAPK1, FYN |
09160 Human Diseases | 09167 Infectious diseases | hsa05132 | Salmonella infection | 1.173E-03 | 7.494E-03 | MAPK1, MAPK14 |
09150 Organismal Systems | 09151 Immune system | hsa04620 | Toll-like receptor signaling pathway | 1.774E-03 | 8.500E-03 | MAPK1, MAPK14 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04668 | TNF signaling pathway | 1.908E-03 | 8.593E-03 | MAPK1, MAPK14 |
09160 Human Diseases | 09167 Infectious diseases | hsa05142 | Chagas disease (American trypanosomiasis) | 1.708E-03 | 8.500E-03 | MAPK1, MAPK14 |
09160 Human Diseases | 09167 Infectious diseases | hsa05145 | Toxoplasmosis | 2.192E-03 | 9.304E-03 | MAPK1, MAPK14 |
09150 Organismal Systems | 09156 Nervous system | hsa04722 | Neurotrophin signaling pathway | 2.265E-03 | 9.304E-03 | MAPK1, MAPK14 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
I00-I99: Diseases of the circulatory system | Cardiac arrhythmias | I47-I49 | TBXAS1; |
NA: NA | Rheumatold arthritis | NA | MAPK14; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | MAPK14; |
C00-D49: Neoplasms | Cancer | C00-C96 | MAPK1; MAPK14; |
J00-J99: Diseases of the respiratory system | Acute lung injury | J80 | MAPK14; |
I00-I99: Diseases of the circulatory system | Angina pectoris | I20 | TBXAS1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | TBXAS1; |
I00-I99: Diseases of the circulatory system | Acute coronary syndrome | I74 | MAPK14; |
K00-K95: Diseases of the digestive system | Inflammatory bowel disease | K50, K51 | MAPK14; TBXAS1; |
NA: NA | Inflammatory diseases | NA | MAPK14; |
N00-N99: Diseases of the genitourinary system | Nephritis | N00-N19, N25-N29 | TBXAS1; |
L00-L99: Diseases of the skin and subcutaneous tissue | Psoriasis | L40 | MAPK14; |
I00-I99: Diseases of the circulatory system | Restenosis | I51.89 | MAPK1; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Arthritis | M00-M25 | MAPK14; |
J00-J99: Diseases of the respiratory system | Asthma | J45 | TBXAS1; |
H00-H59: Diseases of the eye and adnexa | Ocular hypertension | H40.0 | CA4; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA4; CA2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Autoimmune diabetes | E08-E13 | LCK; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
I00-I99: Diseases of the circulatory system | Coronary artery disease | I20-I25 | MAPK14; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; |
NA: NA | Edema | NA | CA2; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
I00-I99: Diseases of the circulatory system | Thromboembolism | I80-I82 | TBXAS1; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MAPK1; |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | MAPK14; |
H00-H59: Diseases of the eye and adnexa | Diabetic retinopathy | H36, E10.3, E11.3, E13.3 | MAPK14; |
J00-J99: Diseases of the respiratory system | Chronic obstructive pulmonary disease | J40-J44, J47 | MAPK14; |
NA: NA | Acute respiratory distress syndrome | NA | MAPK14; |
I00-I99: Diseases of the circulatory system | Thrombosis | I80-I82 | TBXAS1; |